Democratization and Disruption of Biomedical Molecular Imaging with Simple Hyperpolarized Biotracers

Project Description: This project will develop the next generation of non-toxic biotracers to be used as contrast agents for Magnetic Resonance Imaging (MRI) imaging. Contrast agents are used to improve the sensitivity of MRI images. Currently, many MRI contrast agents are toxic and often radioactive. For this technology in development, improvement of MRI signals will be achieved through hyperpolarization of biological molecules. The most significant potential clinical benefits of the technology are increasing the specificity and sensitivity of existing MRI scanners and avoiding the use of radiopharmaceuticals.